Angiotensinamide

This classification denotes a therapeutic hormone with the molecular formula C49H70N14O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7WAL1X78KV, chemically known as l-phenylalanine, n-(1-(n-(n-(n-(n-(n2-l-asparaginyl-l-arginyl)-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)- but generally known as angiotensin amide, which bears US NIH Compound Identifier 5890. European Medicines Agency schedules Angiotensinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05511MIG. The term ANGIOTENSINAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules angiotensin amide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule angiotensinamide under HS 29332990 and SITC 51573. SMILES: O=C(N1C(CCC1)C(=O)NC(CC1CCCCC1)C(=O)O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)CC(=O)N)CCC/N=C(/N)N)C(C)C)CC1CCC(O)CC1)C(C)C)CC1[NH]CNC1.